Pacific Edge upbeat about latest move for new Cxbladder test

Pacific Edge upbeat about latest move for new Cxbladder test
Pacific Edge says Cxbladder Triage Plus delivers “significant performance improvements” compared to its existing tests. Image: Pacific Edge)
Rebecca Howard
Pacific Edge is upbeat about the draft gapfill or reimbursement rates for its new Cxbladder Triage Plus test from the US Centres for Medicare and Medicaid Services.Gapfill prices are proposed reimbursement rates for new or unpriced clinical diagnostic laboratory tests.The median price for Cxbladder Triage Plus is US$1,018 (NZ$1,708), according to the gapfill prices.When finalised, the US Centres for Medicare and Medicaid Services (CMS) price for Triage Plus sets the amount Pacific Edge will be reimbursed for all patients with Medicare and Medic...

More Markets

NZ sharemarket has 'soft day', down 0.5%
Markets Market Close

NZ sharemarket has 'soft day', down 0.5%

The S&P/NZX 50 Index closed down 0.53% or 71.407 points to 13,306.44.

Fletcher Building puts ‘noise’ in the past
Property

Fletcher Building puts ‘noise’ in the past

New directors say shareholders are right to expect more, and they intend to deliver.

More butter, more value: Fonterra’s $75m move to expand production
Primary Sector

More butter, more value: Fonterra’s $75m move to expand production

Fonterra Co-operative Group will invest $75 million to expand butter production at its Clandeboye site in South Canterbury.The move is part of the next phase of strategic investments by the co-op, signalled in its annual result.At the time, chief executive Miles Hurrell said the...

Air NZ expects 1H loss of $30m to $55m
Markets

Air NZ expects 1H loss of $30m to $55m

According to Air NZ, it had anticipated a 2% to 3% revenue uplift.